title: Implementation of the biosimilar pathway: economic and policy issues.
authors: Duke University, USA. grabow@econ.duke.edu
authors: Henry
authors: H
authors: Grabowski
authors: Genia
authors: G
authors: Long
authors: Richard
authors: R
authors: Mortimer
mesh_terms: D001688:Biological Products / Q000191:economics* / Q000627:therapeutic use; D017046:Cost Savings; D004059:Diffusion of Innovation; D017277:Drug Approval / Q000191:economics* / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000191:economics* / Q000592:standards; D004465:Economic Competition; D005062:European Union; D018166:Health Care Reform; D006291:Health Policy; D006801:Humans; D007880:Legislation, Drug; D008484:Medicaid; D006278:Medicare; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D012051:Reimbursement Mechanisms / Q000191:economics* / Q000331:legislation & jurisprudence; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001688:Biological Products; D016568:Drugs, Generic